Bevacizumab for metastatic renal cell carcinoma: a monoclonal antibody in a sea of small molecules

By Pal Sumanta Kumar   Figlin Robert A  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1517-1520

Informa Healthcare

Access to resources Recommend Favorite

Biochemical and molecular markers in renal cell carcinoma: an update and future prospects

By Kashyap M. K.   Kumar A.   Emelianenko N.   Kashyap A.   Kaushik R.   Huang R.   Khullar M.   Sharma S. K.   Singh S. K.   Bhargave A. K.   Upadhyaya S. K.  

Biomarkers, Vol. 10, Iss. 4, 2005-07 ,pp. : 258-294

Informa Healthcare

Access to resources Recommend Favorite

Immunochemotherapy-associated protein patterns in tumour tissue and serum of patients with metastatic renal cell carcinoma

By Walter Martina   Heinze Christian   Steiner Thomas   Pilchowski Rico   von Eggeling Ferdinand   Wunderlich Heiko   Junker Kerstin  

Archives of Physiology and Biochemistry, Vol. 116, Iss. 4-5, 2010-12 ,pp. : 197-207

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma

By Hashmi Mehmood H   Van Veldhuizen Peter J  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 807-817

Informa Healthcare

Access to resources Recommend Favorite

Antigenic targets for renal cell carcinoma immunotherapy

By Vieweg Johannes   Jackson Andrew  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1791-1801

Informa Healthcare

Access to resources Recommend Favorite